These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 2807779

  • 1. Investigation of GAGS on 24-hour and 2-hour urines from calcium oxalate stone formers and healthy subjects.
    Gianotti M, Genestar C, Palou A, Pons A, Conte A, Grases F.
    Int Urol Nephrol; 1989; 21(3):281-8. PubMed ID: 2807779
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Inhibitory activity of whole urine: a comparison of urines from stone formers and healthy subjects.
    Ryall RL, Hibberd CM, Mazzachi BC, Marshall VR.
    Clin Chim Acta; 1986 Jan 15; 154(1):59-67. PubMed ID: 3943225
    [Abstract] [Full Text] [Related]

  • 4. Crystallization properties in urine from calcium oxalate stone formers.
    Tiselius HG, Bek-Jensen H, Fornander AM, Nilsson MA.
    J Urol; 1995 Sep 15; 154(3):940-6. PubMed ID: 7637098
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Study of calcium oxalate crystalluria on renal and vesical urines in stone formers and normal subjects.
    Robert M, Boularan AM, Delbos O, Guiter J, Descomps B.
    Urol Int; 1998 Sep 15; 60(1):41-6. PubMed ID: 9519420
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Comparative study of the circadian rhythmicity in the urinary concentration of glycosaminoglycans in patients of calcium oxalate nephrolithiasis and in healthy adults.
    Sidhu H, Thind SK, Nath R, Vaidyanathan S, Hemal AK, Mandal AK, Krishan K.
    Urol Int; 1989 Sep 15; 44(4):218-21. PubMed ID: 2800054
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Modulatory effect of the 23-kD calcium oxalate monohydrate binding protein on calcium oxalate stone formation during oxalate stress.
    Asokan D, Kalaiselvi P, Varalakshmi P.
    Nephron Physiol; 2004 Sep 15; 97(1):p23-30. PubMed ID: 15153748
    [Abstract] [Full Text] [Related]

  • 13. The effect of Phyllanthus niruri on urinary inhibitors of calcium oxalate crystallization and other factors associated with renal stone formation.
    Freitas AM, Schor N, Boim MA.
    BJU Int; 2002 Jun 15; 89(9):829-34. PubMed ID: 12010223
    [Abstract] [Full Text] [Related]

  • 14. A method for discrimination between calcium oxalate kidney stone formers and normals.
    Sarig S, Garti N, Azoury R, Wax Y, Perlberg S.
    J Urol; 1982 Sep 15; 128(3):645-9. PubMed ID: 6214645
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Significance of glycosaminoglycans for the formation of calcium oxalate stones.
    Hesse A, Wuzel H, Vahlensieck W.
    Am J Kidney Dis; 1991 Apr 15; 17(4):414-9. PubMed ID: 2008909
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Excessive crystal agglomeration with low citrate excretion in recurrent stone-formers.
    Kok DJ, Papapoulos SE, Bijvoet OL.
    Lancet; 1986 May 10; 1(8489):1056-8. PubMed ID: 2871335
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.